American Well Corporation
NYSE:AMWLMedical - Healthcare Information Services
+$0.24 today
- Market cap
- $171.77M
- Beta
- 1.70
- P/E (TTM)
- -1.6
- EPS (TTM)
- -$5.30
Volume 0.06M
Average 0.07M
AMWL Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
American Well CorporationNYSE: AMWL
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 19.4% from a year ago
Cash & equivalents stood at $179.21M at the end of Q1 FY2026, down 19.4% from a year earlier and down 1.7% from the prior quarter. Over 3 fiscal years it compounded at -30.3% a year.
Context
- Cash & equivalents amounted to 55.0% of total assets at the end of Q1 FY2026, up 2.0 pp from a year earlier.
- Cash & equivalents increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -19.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 182.33M USD
- Year-over-year change
- -20.1%
- 4-year CAGR
- -29.7%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 182.33M | -20.1% |
| FY2024 | 2024-12-31 | 228.32M | -38.6% |
| FY2023 | 2023-12-31 | 372.04M | -30.9% |
| FY2022 | 2022-12-31 | 538.55M | -27.8% |
| FY2021 | 2021-12-31 | 746.42M | — |
Cash & Equivalents vs competitors
How AMWL compares with its peers on the latest reported figures
- AMWL's Mar 2026 cash & equivalents of $179.21M is the 2nd highest of the 9 companies compared; the peer median is $53.93M.
- Its year-over-year change of -19.4% is the lowest of 9, against a peer median of +53.3%.
- Cash & equivalents amounts to 55.0% of total assets for AMWL, versus a peer median of 66.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $186.63M | +1204.7% | -47.5% | 98.4% | |
| Mar 2026 | $179.21M | -19.4% | -30.3% | 55.0% | |
| Mar 2026 | $99.37M | +28.7% | -16.4% | 69.1% | |
| Mar 2026 | $99.21M | +101.1% | — | 94.1% | |
| Mar 2026 | $63.17M | +50.0% | +18.3% | 63.6% | |
| Mar 2026 | $44.69M | +24.6% | -20.7% | 96.4% | |
| Mar 2026 | $32.28M | +56.6% | -30.5% | 18.1% | |
| Mar 2026 | $10.01M | -3.4% | +2.5% | 12.6% | |
| Jun 2026 | $365.9K | +107.2% | +81.7% | 3.8% | |
| Peer median (excluding AMWL) | $53.93M | +53.3% | -16.4% | 66.3% | |
Competitors are the stored peer set for AMWL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 746.42M | 538.55M | 372.04M | 228.32M | 182.33M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 51.38M | 58.37M | 54.15M | 71.89M | 49.69M |
| Inventory | 7.53M | 8.74M | 6.65M | 2.86M | 1.19M |
| Other Current Assets | 1.7M | 1.39M | 16.75M | 13.93M | 13.47M |
| Total Current Assets | 827.3M | 626.62M | 449.58M | 316.99M | 246.68M |
| Property, Plant & Equipment (Net) | 18.66M | 14.52M | 11.03M | 7.58M | 4.16M |
| Goodwill | 442.76M | 435.28M | 0 | 0 | 0 |
| Intangible Assets | 152.41M | 134.98M | 120.25M | 101.54M | 66.07M |
| Long-term Investments | 168K | 795K | 1.18M | 1.5M | 795K |
| Tax Assets | 2.03M | (795K) | 0 | 0 | 0 |
| Other Non-current Assets | 2.52M | 6.16M | 7.67M | 8.36M | 6.08M |
| Total Non-current Assets | 618.54M | 590.94M | 140.12M | 118.98M | 77.11M |
| Total Assets | 1.45B | 1.22B | 589.71M | 435.97M | 323.79M |
| Account Payables | 12.16M | 7.24M | 4.86M | 5.02M | 1.65M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 68.84M | 49.51M | 46.37M | 53.23M | 22.63M |
| Other Current Liabilities | 83.84M | 35.97M | 12.14M | 36.07M | 34.73M |
| Total Current Liabilities | 141.63M | 114.06M | 93.8M | 111.26M | 73.21M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 7.06M | 6.29M | 6.09M | 2.78M | 818K |
| Other Non-current Liabilities | 21.59M | 1.57M | 1.43M | 1.17M | 1.08M |
| Total Non-current Liabilities | 43.34M | 19.65M | 15.72M | 8.46M | 2.79M |
| Total Liabilities | 184.96M | 133.71M | 109.52M | 119.72M | 76M |
| Common Stock | 2.62M | 2.77M | 145K | 156K | 165K |
| Retained Earnings | (811.28M) | (1.08B) | (1.76B) | (1.97B) | (2.06B) |
| Accumulated OCI | (6.35M) | (16.97M) | (15.65M) | (15.84M) | (12.1M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 21.62M | 19.97M | 15.97M | 11.47M | 12.21M |
| Total Equity | 1.26B | 1.08B | 480.19M | 316.24M | 247.79M |
| Total Debt | 16.61M | 14.84M | 11.79M | 8.2M | 4.52M |
| Net Debt | (729.8M) | (523.7M) | (360.25M) | (220.12M) | (177.8M) |
American Well Corporation
NYSE:AMWL
Intrinsic Alpha fair value
Locked
Current Price
$11.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.